Showing results (1111-1120 of 1,373) with videos related to
Sort By:
Pageof 138
BMC Public Health|December 5, 2024
Measures of social connectedness in adult populations: a systematic reviewRuth Plackett, Joe Hulin, Clara Mukuria, et al.Biomaterials Science|January 18, 2021
Tetrazine-mediated bioorthogonal removal of 3-isocyanopropyl groups enables the controlled release of nitric oxide <i>in vivo</i>Jianbing Wu, Tao Sun, Chenxi Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancyM Pecherstorfer, Z Herrmann, J J Body, et al.Antimicrobial Agents and Chemotherapy|July 29, 2005
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitorsPatrick F Smith, Gregory K Robbins, Robert W Shafer, et al.Headache|June 26, 2024
The location of pain in cluster headache: Data from the International Cluster Headache QuestionnaireLarry I Schor, Stuart M Pearson, Bruno de Castro Sousa, et al.Journal of Materials Chemistry. B|April 9, 2020
Highly cohesive dual nanoassemblies for complementary multiscale bioimagingAdrien Faucon, Thomas Maldiney, Olivier Clément, et al.Physical Review Letters|August 23, 2002
Deuterium-deuterium fusion dynamics in low-density molecular-cluster jets irradiated by intense ultrafast laser pulsesG Grillon, Ph Balcou, J- P Chambaret, et al.ACS Applied Materials & Interfaces|April 6, 2017
PEGylated Anionic Magnetofluorescent Nanoassemblies: Impact of Their Interface Structure on Magnetic Resonance Imaging Contrast and Cellular UptakeCamille Linot, Julien Poly, Joanna Boucard, et al.Plos One|August 30, 2014
Modeling the dynamics and migratory pathways of virus-specific antibody-secreting cell populations in primary influenza infectionHongyu Miao, Mark Y Sangster, Alexandra M Livingstone, et al.American Journal of Clinical Oncology|June 3, 2009
Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapyPierre Fumoleau, Hernan Cortés-Funes, Amina B Taleb, et al.Pageof 138